Page last updated: 2024-09-04

cv 159 and Disease Models, Animal

cv 159 has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asakura, T; Asano, T; Ishiuchi, A; Jinnouchi, Y; Kamibayashi, M; Kobayashi, HP; Koizumi, S; Kubota, S; Nakano, H; Oowada, S; Otsubo, T; Shimamura, T; Watanabe, T	1

Other Studies

1 other study(ies) available for cv 159 and Disease Models, Animal

Article	Year
The role of the new Ca2+ antagonist, CV159, in hepatic I/R injury-the evaluation of hepatic organ reducing activity using in vivo and ex vivo EPR. The Journal of surgical research, 2008, Volume: 145, Issue:1 Topics: Alanine Transaminase; Animals; Calcium; Calmodulin; Dihydropyridines; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Liver; Male; Mitochondria; Myosin-Light-Chain Kinase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Survival Rate	2008

Article

Year

The role of the new Ca2+ antagonist, CV159, in hepatic I/R injury-the evaluation of hepatic organ reducing activity using in vivo and ex vivo EPR.

The Journal of surgical research, 2008, Volume: 145, Issue:1

Topics: Alanine Transaminase; Animals; Calcium; Calmodulin; Dihydropyridines; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Liver; Male; Mitochondria; Myosin-Light-Chain Kinase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Survival Rate

2008